These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 28274590)
1. Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy. Buisan O; Orsola A; Oliveira M; Martinez R; Etxaniz O; Areal J; Ibarz L Clin Genitourin Cancer; 2017 Aug; 15(4):e697-e706. PubMed ID: 28274590 [TBL] [Abstract][Full Text] [Related]
2. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer. Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982 [TBL] [Abstract][Full Text] [Related]
3. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy. Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209 [TBL] [Abstract][Full Text] [Related]
5. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819 [TBL] [Abstract][Full Text] [Related]
6. Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer. Leibowitz-Amit R; Israel A; Gal M; Atenafu EA; Symon Z; Portnoy O; Laufer M; Dotan Z; Ramon J; Avni D; Fridman E; Berger R Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):790-796. PubMed ID: 27498850 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy. Salari A; Ghahari M; Bitaraf M; Fard ES; Haddad M; Momeni SA; Inanloo SH; Ghahari P; Mohamoud MM; Mohamadzadeh M; Nowroozi MR; Amini E Clin Genitourin Cancer; 2024 Oct; 22(5):102144. PubMed ID: 39032203 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study. Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Black AJ; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand S; Sridhar SS; Black PC Urol Oncol; 2020 Jan; 38(1):3.e17-3.e27. PubMed ID: 31676278 [TBL] [Abstract][Full Text] [Related]
12. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy. von Deimling M; Schuettfort VM; D'Andrea D; Pradere B; Grossmann NC; Kawada T; Yanagisawa T; Majdoub M; Laukhtina E; Rajwa P; Quhal F; Mostafaei H; Fajkovic H; Teoh JY; Moschini M; Karakiewicz PI; Fisch M; Rink M; Shariat SF Clin Genitourin Cancer; 2023 Aug; 21(4):430-441. PubMed ID: 36781346 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011 [TBL] [Abstract][Full Text] [Related]
14. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy. Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma. Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy. Wang R; Yan Y; Liu S; Yao X Biomed Res Int; 2019; 2019():3628384. PubMed ID: 31662975 [TBL] [Abstract][Full Text] [Related]
17. Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival. Rosenblatt R; Lorentzi G; Bahar M; Asad D; Forsman R; Johansson M; Shareef M; Alamdari F; Bergh A; Winqvist O; Sherif A Scand J Urol; 2020 Feb; 54(1):46-51. PubMed ID: 31960752 [No Abstract] [Full Text] [Related]
18. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy? Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. Toh E; Wilson J; Sebag-Montefiore D; Botterill I Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256 [TBL] [Abstract][Full Text] [Related]
20. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study. Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]